Category Press Releases

Spruce Biosciences to Present at March Investor Conferences

Spruce Biosciences, Inc. CEO Javier Szwarcberg to outline pipeline progress and strategic priorities at upcoming healthcare investor events. Spruce Biosciences, Inc. a late-stage biopharmaceutical company dedicated to advancing innovative therapies for neurological disorders with significant unmet medical needs, has announced…